ERCC1-XPF

Stopping Cancer Cells from Repairing their Own DNA Post Treatment: University of Alberta New Drug Shows Potential

Nov 23, 2019 | Cancer, DNA Repair, ERCC1-XPF, Oncology, University of Alberta

University of Alberta researchers has discovered a new class of drug that could contribute to the war against cancer. Based on initial study results, it appears that the drug can halt cancerous cells from repairing themselves after they have been zapped with radiation...

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

159 WEST BROADWAY SUITE 200
SALT LAKE CITY, UT 84101

Stopping Cancer Cells from Repairing their Own DNA Post Treatment: University of Alberta New Drug Shows Potential

Pin It on Pinterest